KCNQ1 Antibody

Polyclonal Antibody

KCNQ1

ATFB1 antibody, ATFB3 antibody, FLJ26167 antibody, IKs producing slow voltage-gated potassium channel subunit alpha antibody, IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1 antibody, Jervell and Lange-Nielsen syndrome 1 antibody, JLNS1 antibody, KCNA8 antibody, KCNA9 antibody, KCNQ1 antibody, KCNQ1_HUMAN antibody, kidney and cardiac voltage dependend K+ channel antibody, KQT-like 1 antibody, Kv1.9 antibody, Kv7.1 antibody, KVLQT1 antibody, long (electrocardiographic) QT syndrome, Ward-Romano syndrome 1 antibody, LQT antibody, LQT1 antibody, Potassium channel, voltage-gated, shaker-relatd subfamily, member 9 antibody, Potassium voltage-gated channel subfamily KQT member 1 antibody, potassium voltage-gated channel, KQT-like subfamily, member 1 antibody, RWS antibody, slow delayed rectifier channel subunit antibody, SQT2 antibody, Voltage-gated potassium channel subunit Kv7.1 antibody, WRS antibody

Fusion protein of human KCNQ1

This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene.

Antigen Affinity Purified

Neuroscience

Fusion protein of Human KCNQ1